glp-1 agonists names Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer Comparing Ozempic, Wegovy and Other
Description
The SUSTAIN-6 trial showed semaglutide specifically reduced non-fatal stroke risk by 39% 17
doi: 10.1016/j.ejphar.2015.09.024 186 SonH.BanasrM.ChoiM.ChaeS
Perkovic V, Tuttle KR, Rossing P et al
First, the class of sodium glucose cotransporter-2 (SGLT2) inhibitors was recently introduced
Nat Rev Endocrinol (2011) 8:22836
